Daniel Faga

President, CEO · AnaptysBio

Daniel Faga (President, CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in AnaptysBio, Inc. (ANAB). The largest single filing was $928K of ANAB (15,017 sh across 5 lots, as filed), executed Mar 27. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.6M

shares × price, as filed

Last traded

Mar 27

Filed Mar 27

Median ADV $28.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ANAB

AnaptysBio, Inc. ANAB · 0 buys · 4 sells 4 filings

Recent filings

ANABSALE AnaptysBio, Inc. View filing → $928K
15,017 sh across 5 lots
Exec Mar 27
Filed Mar 27 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $639K
14,281 sh × $44.71
Exec Jan 8
Filed Jan 9 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $415K
9,202 sh × $45.11
Exec Jan 7
Filed Jan 8 · 5:30 PM ET ANABSALE AnaptysBio, Inc. View filing → $662K
15,309 sh × $43.26
Exec Jan 5
Filed Jan 6 · 5:30 PM ET